{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:26:22Z","timestamp":1788827182330,"version":"build-2803163510"},"reference-count":36,"publisher":"American Association for Cancer Research (AACR)","issue":"2","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Transcriptional profiling has identified five breast cancer subtypes, of which the basal epithelial is most aggressive and correlates with poor prognosis. These tumors display a high degree of cellular heterogeneity and lack established molecular targets, such as estrogen receptor-\u03b1, progesterone receptor, and Her2 overexpression, indicating a need for definitive diagnostic markers. We present evidence that nestin, a previously described marker of regenerative cells in diverse tissues, is expressed in the regenerative compartment of the normal human mammary gland. Colocalization studies indicate two distinct populations of mammary epithelia that express nestin: one expressing cytokeratin 14 (CK14) and \u0394N-p63 and another expressing desmin. Immunohistochemical analysis indicates that \u0394N-p63 and nestin are coordinately expressed during pregnancy in the murine mammary gland. In the embryonal carcinoma cell line NT2\/D1, ectopic \u0394N-p63-\u03b1 disrupts retinoic acid\u2013induced differentiation, thereby preserving expression of nestin; however, small interfering RNA\u2013mediated ablation of nestin is insufficient to promote differentiation, indicating that whereas nestin may identify cells within the regenerative compartment of the mammary gland, it is insufficient to block differentiation and preserve replicative capacity. Immunohistochemical analysis of basal epithelial breast tumors, including those shown to carry BRCA1 mutations, indicates robust expression of nestin and CK14, punctate expression of p63, and low to undetectable levels of desmin expression. Nestin was not detected in other breast cancer subtypes, indicating selectivity for basal epithelial breast tumors. These studies identify nestin as a selective marker of the basal breast cancer phenotype, which displays features of mammary progenitors. [Cancer Res 2007;67(2):501\u201310]<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-4571","type":"journal-article","created":{"date-parts":[[2007,1,18]],"date-time":"2007-01-18T16:53:23Z","timestamp":1169139203000},"page":"501-510","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":98,"title":["Nestin Is Expressed in the Basal\/Myoepithelial Layer of the Mammary Gland and Is a Selective Marker of Basal Epithelial Breast Tumors"],"prefix":"10.1158","volume":"67","author":[{"given":"Hua","family":"Li","sequence":"first","affiliation":[{"name":"1Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratima","family":"Cherukuri","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Cowling","sequence":"additional","affiliation":[{"name":"2Departments of Pharmacology and Toxicology and Genetics, Dartmouth Medical School, Norris Cotton Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Spinella","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cole","sequence":"additional","affiliation":[{"name":"2Departments of Pharmacology and Toxicology and Genetics, Dartmouth Medical School, Norris Cotton Cancer Center;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew K.","family":"Godwin","sequence":"additional","affiliation":[{"name":"4Medical Science Division, Fox Chase Cancer Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Wells","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"DiRenzo","sequence":"additional","affiliation":[{"name":"1Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,1,18]]},"reference":[{"key":"2022061623240860600_B1","doi-asserted-by":"crossref","unstructured":"Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature\u20082000; 406: 747\u201352.","DOI":"10.1038\/35021093"},{"key":"2022061623240860600_B2","doi-asserted-by":"crossref","unstructured":"Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A\u20082001; 98: 10869\u201374.","DOI":"10.1073\/pnas.191367098"},{"key":"2022061623240860600_B3","doi-asserted-by":"crossref","unstructured":"van 't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature\u20082002; 415: 530\u20136.","DOI":"10.1038\/415530a"},{"key":"2022061623240860600_B4","doi-asserted-by":"crossref","unstructured":"West M, Blanchette C, Dressman H, et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A\u20082001; 98: 11462\u20137.","DOI":"10.1073\/pnas.201162998"},{"key":"2022061623240860600_B5","doi-asserted-by":"crossref","unstructured":"Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA\u20082006; 295: 2492\u2013502.","DOI":"10.1001\/jama.295.21.2492"},{"key":"2022061623240860600_B6","doi-asserted-by":"crossref","unstructured":"Collett K, Stefansson IM, Eide J, et al. A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev\u20082005; 14: 1108\u201312.","DOI":"10.1158\/1055-9965.EPI-04-0394"},{"key":"2022061623240860600_B7","doi-asserted-by":"crossref","unstructured":"Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A\u20082003; 100: 8418\u201323.","DOI":"10.1073\/pnas.0932692100"},{"key":"2022061623240860600_B8","doi-asserted-by":"crossref","unstructured":"Chepko G, Smith GH. Mammary epithelial stem cells: our current understanding. J Mammary Gland Biol Neoplasia\u20081999; 4: 35\u201352.","DOI":"10.1023\/A:1018752519356"},{"key":"2022061623240860600_B9","doi-asserted-by":"crossref","unstructured":"Smalley M, Ashworth A. Stem cells and breast cancer: a field in transit. Nat Rev Cancer\u20082003; 3: 832\u201344.","DOI":"10.1038\/nrc1212"},{"key":"2022061623240860600_B10","doi-asserted-by":"crossref","unstructured":"Shackleton M, Vaillant F, Simpson KJ, et al. Generation of a functional mammary gland from a single stem cell. Nature\u20082006; 439: 84\u20138.","DOI":"10.1038\/nature04372"},{"key":"2022061623240860600_B11","doi-asserted-by":"crossref","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A\u20082003; 100: 3983\u20138.","DOI":"10.1073\/pnas.0530291100"},{"key":"2022061623240860600_B12","doi-asserted-by":"crossref","unstructured":"Kaelin WG, Jr. The p53 gene family. Oncogene\u20081999; 18: 7701\u20135.","DOI":"10.1038\/sj.onc.1202955"},{"key":"2022061623240860600_B13","doi-asserted-by":"crossref","unstructured":"Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature\u20081999; 398: 708\u201313.","DOI":"10.1038\/19531"},{"key":"2022061623240860600_B14","doi-asserted-by":"crossref","unstructured":"van Bokhoven H, McKeon F. Mutations in the p53 homolog p63: allele-specific developmental syndromes in humans. Trends Mol Med\u20082002; 8: 133\u20139.","DOI":"10.1016\/S1471-4914(01)02260-2"},{"key":"2022061623240860600_B15","doi-asserted-by":"crossref","unstructured":"Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature\u20081999; 398: 714\u20138.","DOI":"10.1038\/19539"},{"key":"2022061623240860600_B16","doi-asserted-by":"crossref","unstructured":"Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27\u201329, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell\u20081998; 2: 305\u201316.","DOI":"10.1016\/S1097-2765(00)80275-0"},{"key":"2022061623240860600_B17","unstructured":"DiRenzo J, Signoretti S, Nakamura N, et al. Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line. Cancer Res\u20082002; 62: 89\u201398."},{"key":"2022061623240860600_B18","doi-asserted-by":"crossref","unstructured":"van Bokhoven H, Hamel BC, Bamshad M, et al. p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. Am J Hum Genet\u20082001; 69: 481\u201392.","DOI":"10.1086\/323123"},{"key":"2022061623240860600_B19","doi-asserted-by":"crossref","unstructured":"Nylander K, Coates PJ, Hall PA. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. Int J Cancer\u20082000; 87: 368\u201372.","DOI":"10.1002\/1097-0215(20000801)87:3<368::AID-IJC9>3.0.CO;2-J"},{"key":"2022061623240860600_B20","doi-asserted-by":"crossref","unstructured":"Wiese C, Rolletschek A, Kania G, et al. Nestin expression: a property of multi-lineage progenitor cells? Cell Mol Life Sci\u20082004; 61: 2510\u201322.","DOI":"10.1007\/s00018-004-4144-6"},{"key":"2022061623240860600_B21","unstructured":"Seigel GM, Sun W, Salvi R, Campbell LM, Sullivan S, Reidy JJ. Human corneal stem cells display functional neuronal properties. Mol Vis\u20082003; 9: 159\u201363."},{"key":"2022061623240860600_B22","doi-asserted-by":"crossref","unstructured":"Dahlstrand J, Zimmerman LB, McKay RD, Lendahl U. Characterization of the human nestin gene reveals a close evolutionary relationship to neurofilaments. J Cell Sci\u20081992; 103: 589\u201397.","DOI":"10.1242\/jcs.103.2.589"},{"key":"2022061623240860600_B23","doi-asserted-by":"crossref","unstructured":"Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell\u20081990; 60: 585\u201395.","DOI":"10.1016\/0092-8674(90)90662-X"},{"key":"2022061623240860600_B24","doi-asserted-by":"crossref","unstructured":"Foulkes WD. BRCA1 functions as a breast stem cell regulator. J Med Genet\u20082004; 41: 1\u20135.","DOI":"10.1136\/jmg.2003.013805"},{"key":"2022061623240860600_B25","doi-asserted-by":"crossref","unstructured":"Harmes DC, Bresnick E, Lubin EA, et al. Positive and negative regulation of deltaN-p63 promoter activity by p53 and deltaN-p63-alpha contributes to differential regulation of p53 target genes. Oncogene\u20082003; 22: 7607\u201316.","DOI":"10.1038\/sj.onc.1207129"},{"key":"2022061623240860600_B26","doi-asserted-by":"crossref","unstructured":"Li N, Li H, Cherukuri P, Farzan S, Harmes DC, DiRenzo J. TA-p63-gamma regulates expression of DeltaN-p63 in a manner that is sensitive to p53. Oncogene\u20082006; 25: 2349\u201359.","DOI":"10.1038\/sj.onc.1209270"},{"key":"2022061623240860600_B27","doi-asserted-by":"crossref","unstructured":"Nylander K, Vojtesek B, Nenutil R, et al. Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol\u20082002; 198: 417\u201327.","DOI":"10.1002\/path.1231"},{"key":"2022061623240860600_B28","doi-asserted-by":"crossref","unstructured":"Pellegrini G, Dellambra E, Golisano O, et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A\u20082001; 98: 3156\u201361.","DOI":"10.1073\/pnas.061032098"},{"key":"2022061623240860600_B29","doi-asserted-by":"crossref","unstructured":"Candi E, Rufini A, Terrinoni A, et al. Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ\u20082006; 13: 1037\u201347.","DOI":"10.1038\/sj.cdd.4401926"},{"key":"2022061623240860600_B30","doi-asserted-by":"crossref","unstructured":"Vaittinen S, Lukka R, Sahlgren C, et al. The expression of intermediate filament protein nestin as related to vimentin and desmin in regenerating skeletal muscle. J Neuropathol Exp Neurol\u20082001; 60: 588\u201397.","DOI":"10.1093\/jnen\/60.6.588"},{"key":"2022061623240860600_B31","doi-asserted-by":"crossref","unstructured":"Przyborski SA, Morton IE, Wood A, Andrews PW. Developmental regulation of neurogenesis in the pluripotent human embryonal carcinoma cell line NTERA-2. Eur J Neurosci\u20082000; 12: 3521\u20138.","DOI":"10.1046\/j.1460-9568.2000.00230.x"},{"key":"2022061623240860600_B32","doi-asserted-by":"crossref","unstructured":"Andrews PW. Teratocarcinomas and human embryology: pluripotent human EC cell lines. Review article. APMIS\u20081998; 106: 158\u201367; discussion 67\u20138.","DOI":"10.1111\/j.1699-0463.1998.tb01331.x"},{"key":"2022061623240860600_B33","doi-asserted-by":"crossref","unstructured":"Wenk J, Andrews PW, Casper J, et al. Glycolipids of germ cell tumors: extended globo-series glycolipids are a hallmark of human embryonal carcinoma cells. Int J Cancer\u20081994; 58: 108\u201315.","DOI":"10.1002\/ijc.2910580118"},{"key":"2022061623240860600_B34","doi-asserted-by":"crossref","unstructured":"Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer\u20082003; 3: 895\u2013902.","DOI":"10.1038\/nrc1232"},{"key":"2022061623240860600_B35","doi-asserted-by":"crossref","unstructured":"Sahlgren CM, Mikhailov A, Hellman J, et al. Mitotic reorganization of the intermediate filament protein nestin involves phosphorylation by cdc2 kinase. J Biol Chem\u20082001; 276: 16456\u201363.","DOI":"10.1074\/jbc.M009669200"},{"key":"2022061623240860600_B36","doi-asserted-by":"crossref","unstructured":"Sahlgren CM, Mikhailov A, Vaittinen S, et al. Cdk5 regulates the organization of Nestin and its association with p35. Mol Cell Biol\u20082003; 23: 5090\u2013106.","DOI":"10.1128\/MCB.23.14.5090-5106.2003"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/2\/501\/2866462\/501.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/2\/501\/2866462\/501.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:32:00Z","timestamp":1655436720000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/2\/501\/533449\/Nestin-Is-Expressed-in-the-Basal-Myoepithelial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,15]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2007,1,18]]},"published-print":{"date-parts":[[2007,1,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-4571","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,15]]}}}